Ancora Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,242
Closed -$15.7K 2548
2025
Q4
$15.7K Buy
+2,242
New +$17.6K ﹤0.01% 1651
2024
Q4
Sell
-609
Closed -$5.59K 1879
2024
Q3
$5.59K Hold
609
﹤0.01% 1430
2024
Q2
$5.96K Hold
609
﹤0.01% 1406
2024
Q1
$9.2K Hold
609
﹤0.01% 1340
2023
Q4
$13.1K Hold
609
﹤0.01% 1242
2023
Q3
$11.3K Buy
+609
New +$14.2K ﹤0.01% 1261
2023
Q2
Sell
-150
Closed -$3.88K 1912
2023
Q1
$3.88K Buy
+150
New +$4.01K ﹤0.01% 1437
2022
Q4
Sell
-4
Closed 1945
2022
Q3
$0 Sell
4
-180
-98% -$6.32K ﹤0.01% 2162
2022
Q2
$6K Buy
184
+4
+2% +$170 ﹤0.01% 1725
2022
Q1
$13K Sell
180
-13
-7% -$937 ﹤0.01% 1667
2021
Q4
$18K Buy
193
+13
+7% +$1.55K ﹤0.01% 1625
2021
Q3
$23K Hold
180
﹤0.01% 1441
2021
Q2
$30K Buy
180
+40
+29% +$6.48K ﹤0.01% 1234
2021
Q1
$25K Buy
+140
New +$32.5K ﹤0.01% 1248
2020
Q4
Sell
-10
Closed -$2K 1533
2020
Q3
$2K Buy
+10
New +$2.12K ﹤0.01% 1329

Other funds holding TDOC

Ancora Advisors's TDOC Position: Q1 2026 in Review

Ancora Advisors sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 2,242 shares — an estimated $15.7K sold.

Ancora Advisors first reported a position in TDOC in Q3 2020 and held it in 15 quarters. The position peaked at $30K in Q2 2021. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Ancora Advisors reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Ancora Advisors sold 2,242 Teladoc Health shares in Q1 2026, an estimated $15.7K.
  • Ancora Advisors first reported a position in Teladoc Health in Q3 2020 and held it in 15 quarters.
  • Ancora Advisors's Teladoc Health position peaked at $30K in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.